ÂsÄý³æ­Ó¤å³¹
¤pÃa³J
Elite Member
 
¤pÃa³Jªº¤jÀY·Ó
 

¥[¤J¤é´Á: Dec 2003
±zªº¦í§}: °°¤jÄG¤l¦B¤HXD
¤å³¹: 7,327
¤Þ¥Î:
§@ªÌtangdon
¬°¤°»òFDA¨S¦³µo§G¥ô¦óÃö©ó¤T»EÙæÓi¦w¥þ¾¯¶q¤è­±ªº«H®§
¤§«e¦³¤H»¡¹L¤H
¨S¤H·|·Q¨ì«D­¹«~²K¥[ª«ªº¤T»EÙæÓi·|³Q¥[¤J­¹«~¤¤ ¤@¤@|||

©Ò¥H¬ü°ê¤~·|¥ß¨è¤U¥O¸T¤î

´N§Ú¤§«eÂà¶Kªº¤ù¬q¨Ó»¡
¤Þ¥Î:
(3) Tolerable Daily Intake (TDI):

³oÀ³¸Ó¬O³Ì³Q»~¸Ñªº¼Æ­È¤F, ­º¥ý§Ú­Ì¥²¶·¥ý¤F¸Ñ, TDI¬O¥Î¦b
"¤£¸Ó¦s¦b©ó­¹«~¤¤" ªºª«½èªº, Acceptable Daily Intake
(ADI) ¤~¬O¥Î¦b­¹«~²K¥[ª«¤Wªº, ¦]¦¹¬Ý¨ìTDI, ´Nªí¥Ü¤F¸Óª«½è
µ´¹ï¤£¸Ó³Qµø¬°¬O­¹«~²K¥[ª«, ¦ÓÀ³¸Ó³Qµø¬°¬O¦³®`ª«½è

¥Ñ©ó¬OTDI¬O¹ï¦³®`ª«½è¦Ó¤£¬O­¹ª«, ©Ò¥H°ò©ó¹D¼w¦]¯À, ¤HÅé
¹êÅç¬O¤£¥i¯àªº, ¥u¯à°µ°Êª«¹êÅç, ¦]¦¹«e­±¦³¤H½èºÃFDA¤å¥ó
ùتºTDI¨S¦³°µ¤HÅé¸ÕÅç, ³o¬O§¹¥þnonsenseªº½èºÃ

¦ÓTDI¬O¥ÑNOAEL (no-observed-adverse-effect-levels)±o¨Ó,
¦p¦r­±©Ò­z, NOAEL§Y¬O¦b¹êÅ礤¨S¦³Æ[¹î¨ì¥ô¦ó­t­±²{¶Hªº¾¯¶q
¤W­­, ³o©MLD50¤£¦P, ¤£¬O¦º¤F¤~ºâ¦Ó¬O¥u­n¦³¥ô¦ó²§±`³£ºâ,
©Ò¥H«e­±¦³¤H½èºÃTDI¥u¯à¤ÏÀ³­P¦º²v¦Ó¤£¯à¤ÏÀ³­P¯f²v, ³o¤@¼Ë
¬Ononsenseªº½èºÃ

¦bFDAªº¤å¥ó¤¤, ¤T»EÙæÓiªºNOAEL¬O 63 mg/kg bw/day, ³o­Ó¼Æ
­È¥²¶·¦A°£¥H10¥H®e³\ª«ºØ®t²§ªº­·ÀI(¦]¬°°µªº¬O°Êª«¹êÅç),
µM«á¦A°£¥H10¥H®e³\­ÓÅé®t²§ªº­·ÀI, ³oºÙ¬° safety/uncertainty
factors (SF/UF), ³Ì«á©Ò±o¨ìªº 0.63 mg/kg bw/day ´N¬OTDI,
©Ò¥H«e­±¦³¤H½èºÃ¦Ñ¹«¹êÅ礣¯à®M¥Î¨ì¤H¨­¤W, ¦ý³o­·ÀI¨ä¹ê¤w¸g
¦bTDIªº­pºâ¹Lµ{ùØ­±³Q¦ô­p¶i¥h¤F

¯u¥¿¸Ó½èºÃªºÂI¬O¦~ÄÖ°ÝÃD, ¹ïÀ¦¥®¨à¦Ó¨¥, TDIÀ³¸Ó¦A¤U­°,
¬Æ¦Ü¥i¤U­°10­¿³£¤£¬°¹L

¤T»EÙæÓi¬OÄÝ©óTDI¡A°ò¥»¤W¬O¤£¯à¥[¶i­¹«~ªº¡A©Ò¥HFDA¤]¤£·|¯S§O¥h¼g³W½d
__________________
³o¦~ÀY¡A°Q½×°Ï°Ó®a¤ñª±®a¦h¡F¥~¦æ¤ñ¤º¦æ§ó¦³»¡ªA¤O¡F²Ê»sÄê³yªº¸­¯\¶²¤ñ¥Î¤ß¼gªº´ú¸Õ¤å§ó¦h¦^À³
¶}©l¾ÇµÛ¦h¥h¸Ñ¨M¨ä¥L¤Hªº°ÝÃD¨Ó¨ú¥N¼L¬¶¡A´N·í§@¬O¤@ºØ¦^õX§a!
ÁÙ¦b©ê«è¬°Ô£¨S¦³·sªº¤å³¹¨S¦³¦nªº¤º®e¡A¦ó¤£·Q·Q¦Û¤v°^Äm¤F¤°»ò¡H
¦A¨£!«¥­Ì¹Ú¸Ì¨£

PS¡G§AÁÙ¦b¶RÂû±Æ©±ªº²£«~¶Ü....½Ð¸C¤j²´¬Ý²M·¡¡A¥H§K¦¨¬°¤U¤@­Ó¨üÄFªº¹ï¶H
ÂÂ 2008-09-25, 09:23 PM #337
¦^À³®É¤Þ¥Î¦¹¤å³¹
¤pÃa³JÂ÷½u¤¤